Pre Seed Round - Synamics Therapeutics
Investment Firm
Overview
Pioneering AI-Driven Drug Discovery to Combat Drug Resistance in Cancer
Announced Date
Jul 10, 2024
Funding Type
Pre Seed
Highlights
Location
Europe
Social
Investor Lead
Participant Investors
1
| Investor Name |
|---|
 Per Falholt |
Round Details and Background
Synamics Therapeutics raised an undisclosed amount on 2024-07-10 in Pre Seed Round
Pioneering AI-Driven Drug Discovery to Combat Drug Resistance in Cancer
Company Funding History
1
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Jul 10, 2024 |  Pre Seed Round - Synamics Therapeutics | 2 | - | undefined |
Recent Activity
There is no recent news or activity for this profile.